Viridian Therapeutics, Inc.\DE Quarterly Other Assets, Noncurrent in USD from Q4 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Viridian Therapeutics, Inc.\DE quarterly Other Assets, Noncurrent history and growth rate from Q4 2016 to Q3 2024.
  • Viridian Therapeutics, Inc.\DE Other Assets, Noncurrent for the quarter ending September 30, 2024 was $853K, a 32.5% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $853K -$410K -32.5% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $659K -$525K -44.3% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $555K -$427K -43.5% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $604K -$378K -38.5% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $1.26M +$110K +9.54% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $1.18M -$325K -21.5% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $982K -$560K -36.3% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $982K -$509K -34.1% Dec 31, 2022 10-K 2024-02-27
Q3 2022 $1.15M -$304K -20.9% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $1.51M +$1.41M +1456% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $1.54M +$1.54M +154100% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $1.49M +$1.49M +149000% Dec 31, 2021 10-K 2023-03-09
Q3 2021 $1.46M +$1.46M +145600% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $97K +$96K +9600% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $1K Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $1K +$1K Dec 31, 2020 10-K 2022-03-11
Q3 2020 $1K +$1K Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $1K -$49K -98% Jun 30, 2020 10-Q 2020-08-05
Q4 2019 $0 -$50K -100% Dec 31, 2019 10-K 2021-03-26
Q3 2019 $0 -$50K -100% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $50K $0 0% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $50K $0 0% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $50K $0 0% Dec 31, 2018 10-K 2020-03-13
Q3 2018 $50K $0 0% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 $50K $0 0% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 $50K -$208K -80.6% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $50K -$208K -80.6% Dec 31, 2017 10-K 2019-03-14
Q3 2017 $50K Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $50K Jun 30, 2017 10-Q 2017-08-11
Q1 2017 $258K Mar 31, 2017 10-Q 2017-05-11
Q4 2016 $258K Dec 31, 2016 10-K 2018-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.